These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28455959)

  • 1. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
    Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
    Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis.
    Niu M; He Y; Xu J; Ding L; He T; Yi Y; Fu M; Guo R; Li F; Chen H; Chen YG; Xiao ZJ
    PLoS Biol; 2021 Feb; 19(2):e3001113. PubMed ID: 33626035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verteporfin inhibits TGF-β signaling by disrupting the Smad2/3-Smad4 interaction.
    Nong J; Shen S; Hong F; Xiao F; Meng L; Li P; Lei X; Chen YG
    Mol Biol Cell; 2024 Jul; 35(7):ar95. PubMed ID: 38696259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.
    Chen N; Balasenthil S; Reuther J; Frayna A; Wang Y; Chandler DS; Abruzzo LV; Rashid A; Rodriguez J; Lozano G; Cao Y; Lokken E; Chen J; Frazier ML; Sahin AA; Wistuba II; Sen S; Lott ST; Killary AM
    Cancer Discov; 2013 Oct; 3(10):1172-89. PubMed ID: 23838884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA; Parvani JG; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMAD4 mutations do not preclude epithelial-mesenchymal transition in colorectal cancer.
    Frey P; Devisme A; Rose K; Schrempp M; Freihen V; Andrieux G; Boerries M; Hecht A
    Oncogene; 2022 Feb; 41(6):824-837. PubMed ID: 34857888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncanonical TGF-β signaling during mammary tumorigenesis.
    Parvani JG; Taylor MA; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential.
    Miah S; Banks CAS; Ogunbolude Y; Bagu ET; Berg JM; Saraf A; Tettey TT; Hattem G; Dayebgadoh G; Kempf CG; Sardiu M; Napper S; Florens L; Lukong KE; Washburn MP
    Sci Adv; 2019 Oct; 5(10):eaaw3113. PubMed ID: 31681835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mesenchymal-like subpopulation in non-neuroendocrine SCLC contributes to metastasis.
    Jin Y; Xiao T; Feng Y; Yang J; Guo C; Hu L; Ji H
    J Genet Genomics; 2021 Jul; 48(7):571-581. PubMed ID: 34373217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transition.
    Lin J; Hou L; Zhao X; Zhong J; Lv Y; Jiang X; Ye B; Qiao Y
    Mol Ther; 2024 Jun; 32(6):1956-1969. PubMed ID: 38627967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spheroid assay to measure TGF-β-induced invasion.
    Naber HP; Wiercinska E; Ten Dijke P; van Laar T
    J Vis Exp; 2011 Nov; (57):. PubMed ID: 22126971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IBSP Promotes Breast Cancer Bone Metastasis and Proliferation via BMP-SMAD Signaling Pathway.
    Ding W; Lv D; Wang M; Pei D
    Cancer Rep (Hoboken); 2024 Aug; 7(8):e2153. PubMed ID: 39118232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGS10 deficiency facilitates distant metastasis by inducing epithelial-mesenchymal transition in breast cancer.
    Liu Y; Jiang Y; Qiu P; Ma T; Bai Y; Bu J; Hu Y; Jin M; Zhu T; Gu X
    Elife; 2024 Aug; 13():. PubMed ID: 39145770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer.
    Hurwitz E; Parajuli P; Ozkan S; Prunier C; Nguyen TL; Campbell D; Friend C; Bryan AA; Lu TX; Smith SC; Razzaque MS; Xu K; Atfi A
    J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36828547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Patterns of Grainyhead-Like 2 and Ovo-Like 2 in Mouse Mammary Gland Development During Pregnancy, Lactation, and Weaning.
    Elfeky M; Matsuoka S; Yamamoto I; Elewa YHA; Nakamura K; Suzuki H; Kamikawa A; Okamatu-Ogura Y; Kimura K
    Microsc Microanal; 2024 Jul; 30(3):552-563. PubMed ID: 38833344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PyMT-1099, a versatile murine cell model for EMT in breast cancer.
    Saxena M; Kalathur RKR; Neutzner M; Christofori G
    Sci Rep; 2018 Aug; 8(1):12123. PubMed ID: 30108334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
    Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
    Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer cell mesenchymal transition and metastasis directed by DAP5/eIF3d-mediated selective mRNA translation.
    Alard A; Katsara O; Rios-Fuller T; Parra C; Ozerdem U; Ernlund A; Schneider RJ
    Cell Rep; 2023 Jun; 42(6):112646. PubMed ID: 37314929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
    Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
    Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complexities of TGF-β action during mammary and squamous cell carcinogenesis.
    Connolly EC; Akhurst RJ
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2138-49. PubMed ID: 21619543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.